Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Aortic Stent Grafts Pipeline Market Report Overview

Aortic stent grafts are used to reinforce a weakened aorta to prevent ruptures. They can be of allografts or synthetic materials. The aortic stent grafts pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Abdominal Aortic Stent Grafts

·       Thoracic Aortic Stent Grafts

·       Fenestrated

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       Australia

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Shonin

·       TGA

Leading Companies ·       Affluent Medical SASU

·       Angiolutions UG

·       APT Medical Inc.

·       Artivion Inc.

·       Becton Dickinson and Co.

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Aortic Stent Grafts Pipeline Market by Segments

The key segments of the aortic stent grafts pipeline market are abdominal aortic stent grafts, thoracic aortic stent grafts, and fenestrated. As of September 2024, abdominal aortic stent grafts accounted for the highest share of pipeline products.

Aortic Stent Grafts Pipeline Market Analysis by Segments, 2024 (%)

Aortic Stent Grafts Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Aortic Stent Grafts Pipeline Market Segmentation by Territories

A few of the key territories with the aortic stent grafts pipeline market are the US, Europe, China, Japan, and Australia. As of September 2024, the US accounted for the highest number of pipeline products.

Aortic Stent Grafts Pipeline Market Analysis by Territories, 2024 (%)

Aortic Stent Grafts Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Aortic Stent Grafts Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the aortic stent grafts pipeline products market are PMA, CE, NMPA, Shonin, and TGA. As of September 2024, PMA was the most followed pathway for pipeline products in the aortic stent grafts market.

Aortic Stent Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Aortic Stent Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Aortic Stent Grafts Pipeline Market – Competitive Landscape

A few of the key companies associated with the aortic stent grafts pipeline market are Affluent Medical SASU, Angiolutions UG, APT Medical Inc., Artivion Inc., and Becton Dickinson and Co., among others.

Artivion Inc.: Headquartered in Kennesaw, Georgia, the US, it is a medical device company that specializes in the manufacturing, processing, and distribution of medical devices and implantable human tissues. The company’s product portfolio includes aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion’s products are primarily used in cardiac and vascular surgeries, catering to patients with aortic conditions.

Becton Dickinson and Co (BD): Headquartered in New Jersey, the US, it is a medical technology company that manufactures and sells medical devices, reagents, and instruments. Its major products include syringes and pen needles, intravenous catheters, infusion pumps and disposables, and clinical research tools, among others. BD offers its products for life science researchers, healthcare institutions, clinical laboratories, the pharmaceutical industry, and the general public.

Aortic Stent Grafts Pipeline Market Analysis by Companies, 2024

Aortic Stent Grafts Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Aortic Stent Grafts Pipeline Market Segments Outlook (2024)

  • Abdominal Aortic Stent Grafts
  • Thoracic Aortic Stent Grafts
  • Fenestrated

Aortic Stent Grafts Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • Australia

Aortic Stent Grafts Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • Shonin
  • TGA

Scope

This report provides:

  • Extensive coverage of the aortic stent grafts under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of aortic stent grafts and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of aortic stent grafts under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Affluent Medical SASU
Angiolutions UG
APT Medical Inc
Artivion Inc
Becton Dickinson and Co
Beijing Tianzhu Ruichang Medical Technology Co Ltd
BiFlow Medical Ltd
BioQ Devices Pty Ltd
Cook Medical Inc
Cytograft Tissue Engineering Inc (Inactive)
Endologix LLC
Endoluminal Sciences Pty Ltd
EndoSpan Ltd
Evasc Medical Systems Corp
Hadassah Medical Center
Hangzhou Endonom Medtech Co Ltd
Intressa Vascular SA
Johns Hopkins University
JOTEC GmbH
Kawasumi Laboratories Inc
Lifetech Scientific (Shenzhen) Co Ltd
Lombard Medical Technologies Inc.
Lombard Medical Technologies Ltd (Inactive)
Medical University of Vienna
Medtronic Plc
Merit Medical Systems Inc
MicroPort Scientific Corp
PerMed Biomedical Engineering Co Ltd
Red Vascular Technologies LLC
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stanford University
Terumo Aortic
Terumo Corp
The Lundquist Institute
TriVascular Inc
University of Arizona
University of Colorado Denver
University of Kentucky
University of Limerick
University of Nebraska Medical Center
Venus Medtech Hangzhou Inc
W. L. Gore & Associates Inc
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Aortic Stent Grafts Overview

3 Products under Development

3.1 Aortic Stent Grafts – Pipeline Products by Stage of Development

3.2 Aortic Stent Grafts – Pipeline Products by Segment

3.3 Aortic Stent Grafts – Pipeline Products by Territory

3.4 Aortic Stent Grafts – Pipeline Products by Regulatory Path

3.5 Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

3.6 Aortic Stent Grafts – Ongoing Clinical Trials

4 Aortic Stent Grafts – Pipeline Products under Development by Companies

4.1 Aortic Stent Grafts Companies – Pipeline Products by Stage of Development

4.2 Aortic Stent Grafts – Pipeline Products by Stage of Development

5 Aortic Stent Grafts Companies and Product Overview

5.1 Affluent Medical SASU Company Overview

5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview

5.2 Angiolutions UG Company Overview

5.2.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview

5.3 APT Medical Inc Company Overview

5.3.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Artivion Inc Company Overview

5.4.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Becton Dickinson and Co Company Overview

5.5.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

5.6 Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview

5.6.1 Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.7 BiFlow Medical Ltd Company Overview

5.7.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.8 BioQ Devices Pty Ltd Company Overview

5.8.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.9 Cook Medical Inc Company Overview

5.9.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Cytograft Tissue Engineering Inc (Inactive) Company Overview

5.10.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.11 Endologix LLC Company Overview

5.11.1 Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview

5.12 Endoluminal Sciences Pty Ltd Company Overview

5.12.1 Endoluminal Sciences Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.13 EndoSpan Ltd Company Overview

5.13.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.14 Evasc Medical Systems Corp Company Overview

5.14.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

5.15 Hadassah Medical Center Company Overview

5.15.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.16 Hangzhou Endonom Medtech Co Ltd Company Overview

5.16.1 Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.17 Intressa Vascular SA Company Overview

5.17.1 Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview

5.18 Johns Hopkins University Company Overview

5.18.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.19 JOTEC GmbH Company Overview

5.19.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.20 Kawasumi Laboratories Inc Company Overview

5.20.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

5.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview

5.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.22 Lombard Medical Technologies Inc. Company Overview

5.22.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.23 Lombard Medical Technologies Ltd (Inactive) Company Overview

5.23.1 Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.24 Medical University of Vienna Company Overview

5.24.1 Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview

5.25 Medtronic Plc Company Overview

5.25.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.26 Merit Medical Systems Inc Company Overview

5.26.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 MicroPort Scientific Corp Company Overview

5.27.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.28 PerMed Biomedical Engineering Co Ltd Company Overview

5.28.1 PerMed Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.29 Red Vascular Technologies LLC Company Overview

5.29.1 Red Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

5.30 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview

5.30.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.31 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.31.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

5.32 St. Jude Medical LLC Company Overview

5.32.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.33 Stanford University Company Overview

5.33.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

5.34 Terumo Aortic Company Overview

5.34.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview

5.35 Terumo Corp Company Overview

5.35.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

5.36 The Lundquist Institute Company Overview

5.36.1 The Lundquist Institute Pipeline Products & Ongoing Clinical Trials Overview

5.37 TriVascular Inc Company Overview

5.37.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview

5.38 University of Arizona Company Overview

5.38.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

5.39 University of Colorado Denver Company Overview

5.39.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview

5.40 University of Kentucky Company Overview

5.40.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

5.41 University of Limerick Company Overview

5.41.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

5.42 University of Nebraska Medical Center Company Overview

5.42.1 University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.43 Venus Medtech Hangzhou Inc Company Overview

5.43.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

5.44 W. L. Gore & Associates Inc Company Overview

5.44.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview

5.45 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

5.45.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Aortic Stent Grafts- Recent Developments

6.1 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

6.2 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.3 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.4 Aug 23, 2024: Abbott Vascular Receives Additional HDE Clearance for Graftmaster RX Coronary Stent Graft System

6.5 Aug 08, 2024: Terumo India Launches Treo Abdominal Stent-graft System

6.6 Aug 01, 2024: Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings

6.7 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance

6.8 Jul 15, 2024: Abbott Vascular Receives Additional Humanitarian Device Exemption For Graftmaster RX Coronary Stent Graft System

6.9 Jul 03, 2024: Endospan secures $25m in funding for NEXUS Stent Graft System approval

6.10 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings

6.11 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024

6.12 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.13 Apr 29, 2024: Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

6.14 Apr 07, 2024: MicroPort Endovastec Completes Its First Implantation of Cratos in Pre-Market Clinical Study in the EU and Japan

6.15 Mar 14, 2024: Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit

6.16 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.17 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company

6.18 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering

6.19 Jan 31, 2024: First Patient Treated in the Clinical Study of the ZENITH FENESTRATED+ Endovascular Graft

6.20 Jan 30, 2024: Endospan Releases Early TRIOMPHE IDE Study Results at Society of Thoracic Surgeons

6.21 Jan 29, 2024: W. L. Gore & Associates Obtains Pre-Market Approval (PMA) for GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis

6.22 Jan 29, 2024: Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting

6.23 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results

6.24 Dec 21, 2023: Gore Announces First Patient Implant in the Arise Ii Pivotal Study of the Gore Ascending Stent Graft

6.25 Nov 09, 2023: Artivion Announces Completion of Enrollment in PERSEVERE Trial

6.26 Oct 30, 2023: MicroPort Endovastec Completes Its First Implantation of Castor Branched Stent-Graft and Hercules-LP Stent Graft in Singapore

6.27 Oct 05, 2023: Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting

6.28 Sep 21, 2023: Microport Endovastec Completes the First Clinical Implantation of Minos Stent Graft System in Azerbaijan

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Aortic Stent Grafts – Pipeline Products by Stage of Development

Aortic Stent Grafts – Pipeline Products by Segment

Aortic Stent Grafts – Pipeline Products by Territory

Aortic Stent Grafts – Pipeline Products by Regulatory Path

Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

Aortic Stent Grafts – Ongoing Clinical Trials

Aortic Stent Grafts Companies – Pipeline Products by Stage of Development

Aortic Stent Grafts – Pipeline Products by Stage of Development

Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview

Kardiozis – Product Status

Kardiozis – Product Description

Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview

Vascular Graft (A3-Shield) – Product Status

Vascular Graft (A3-Shield) – Product Description

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Thoracic Aortic Stent – Product Status

Thoracic Aortic Stent – Product Description

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview

Neo 2.0 – Product Status

Neo 2.0 – Product Description

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

Low Profile Arterial Stent Graft – Product Status

Low Profile Arterial Stent Graft – Product Description

Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Three-Branch Thoracic Aorta Stent Graft System – Product Status

Three-Branch Thoracic Aorta Stent Graft System – Product Description

BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nitinol Side Branch Stent – Product Status

Nitinol Side Branch Stent – Product Description

BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

BioQ Aortic Stent Graft Assist – Product Status

BioQ Aortic Stent Graft Assist – Product Description

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Zenith Fenestrated+ Endovascular Graft – Product Status

Zenith Fenestrated+ Endovascular Graft – Product Description

Zenith P-Branch – Product Status

Zenith P-Branch – Product Description

Cook Medical Inc – Ongoing Clinical Trials Overview

Zenith P-Branch – Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts

Zenith Fenestrated+ Endovascular Graft – Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms

Zenith Fenestrated+ Endovascular Graft – Zenith Fenestrated+ Endovascular Graft Clinical Study

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

LifeJacket AAA Stent Graft – Product Status

LifeJacket AAA Stent Graft – Product Description

Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview

AFX2 Bifurcated Endograft System – Product Status

AFX2 Bifurcated Endograft System – Product Description

AFX3 – Product Status

AFX3 – Product Description

AFX4 – Product Status

AFX4 – Product Description

Nellix 3.5 – Product Status

Nellix 3.5 – Product Description

Nellix CHEVAS – Product Status

Nellix CHEVAS – Product Description

Nellix With Snorkels – Product Status

Nellix With Snorkels – Product Description

Next Gen EVAS – Product Status

Next Gen EVAS – Product Description

Paravisceral System – Product Status

Paravisceral System – Product Description

Ventana 2 – Product Status

Ventana 2 – Product Description

Xpand BX Covered Stent – Product Status

Xpand BX Covered Stent – Product Description

Endologix LLC – Ongoing Clinical Trials Overview

Nellix CHEVAS – Prospective, Multicenter, Non-randomized Study with Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms

Endoluminal Sciences Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

Stent-Graft With Adhesive Delivery Platform – Product Status

Stent-Graft With Adhesive Delivery Platform – Product Description

EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nexus Aortic Arch Stent Graft System – Product Status

Nexus Aortic Arch Stent Graft System – Product Description

EndoSpan Ltd – Ongoing Clinical Trials Overview

Nexus Aortic Arch Stent Graft System – A Multi-arm, Multi-center, Non-randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch

Nexus Aortic Arch Stent Graft System – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain”

Nexus Aortic Arch Stent Graft System – Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS DUO™ Aortic Arch Stent Graft System

Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

TAS System – Product Status

TAS System – Product Description

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview

In Situ Weldable Hybrid Stent – Product Status

In Situ Weldable Hybrid Stent – Product Description

Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

WeFlow-Arch Modeler Embedded Branch Stent Graft System – Product Status

WeFlow-Arch Modeler Embedded Branch Stent Graft System – Product Description

WeFlow-Tbranch Stent Graft System – Product Status

WeFlow-Tbranch Stent Graft System – Product Description

Hangzhou Endonom Medtech Co Ltd – Ongoing Clinical Trials Overview

WeFlow-Arch Modeler Embedded Branch Stent Graft System – Guo’s Aortic Arch Reconstruction: The Prospective, Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

WeFlow-Tbranch Stent Graft System – Guo’s Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch Unique Embedded Aortic Triple-branch Arch Stent Graft System (GENIUS Study)

WeFlow-Tbranch Stent Graft System – Guo’s Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: A Multicenter Pilot Study (Graft Study)

WeFlow-Tbranch Stent Graft System – Guo’s Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System (GUEST Study)

WeFlow-Tbranch Stent Graft System – New Technology Clinical Study on the Safety and Efficacy of WeFlow-Tribranch Aortic Arch Stent Graft System in the Treatment of Patients with Aortic Arch Dissection

Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview

Bifurcated Multilayer Flow Modulator Kit – Product Status

Bifurcated Multilayer Flow Modulator Kit – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Scaly Aortic Stent Graft – Product Status

Scaly Aortic Stent Graft – Product Description

JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview

E-liac Stent Graft System – Product Status

E-liac Stent Graft System – Product Description

E-Ventus SX – Product Status

E-Ventus SX – Product Description

E-Vita Open Neo – Product Status

E-Vita Open Neo – Product Description

JOTEC GmbH – Ongoing Clinical Trials Overview

E-liac Stent Graft System – Prospective Multicenter Registry to Examine the Real-world Performance of the E-liac Stent Graft System for Treatment of Uni- or Bilateral Aorto-iliac or Iliac Aneurysms

E-Vita Open Neo – A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS

E-Vita Open Neo – NEO – E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections

E-Vita Open Neo – NEOS-APAC – Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO

Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

Abdominal Aortic Aneurysm Stent Graft – Product Status

Abdominal Aortic Aneurysm Stent Graft – Product Description

Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

G-Branch Thoracic-Abdominal Aorta Stent Graft System – Product Status

G-Branch Thoracic-Abdominal Aorta Stent Graft System – Product Description

Lifetech Scientific (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview

G-Branch Thoracic-Abdominal Aorta Stent Graft System – Guo’s Renovisceral Artery Reconstruction-1: A Prospective, Multicenter, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a Multi-branched Stent Graft System for Thoracoabdominal Aortic Aneurysm (GUARANTEE Study)

G-Branch Thoracic-Abdominal Aorta Stent Graft System – Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm

Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

FEVAR – Product Status

FEVAR – Product Description

TEVAR – Product Status

TEVAR – Product Description

Lombard Medical Technologies Inc. – Ongoing Clinical Trials Overview

TEVAR – Scandinavian Trial of Uncomplicated Aortic Dissection Therapy

Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Low Profile Stent Graft – Product Status

Low Profile Stent Graft – Product Description

Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview

Cylindrical Stent Graft – Product Status

Cylindrical Stent Graft – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

Endurant Evo AAA Stent Graft System – Product Status

Endurant Evo AAA Stent Graft System – Product Description

Unitary Manifold Stent Graft System – Product Status

Unitary Manifold Stent Graft System – Product Description

Valiant Mona LSA System – Product Status

Valiant Mona LSA System – Product Description

Valiant TAAA Stent Graft System – Product Status

Valiant TAAA Stent Graft System – Product Description

Medtronic Plc – Ongoing Clinical Trials Overview

Valiant TAAA Stent Graft System – Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms

Valiant TAAA Stent Graft System – Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms

Unitary Manifold Stent Graft System – Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms

Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

WRAPSODY Endovascular Stent Graft – Arteriovenous Fistula – Product Status

WRAPSODY Endovascular Stent Graft – Arteriovenous Fistula – Product Description

WRAPSODY Endovascular Stent Graft – Arteriovenous Graft – Product Status

WRAPSODY Endovascular Stent Graft – Arteriovenous Graft – Product Description

Merit Medical Systems Inc – Ongoing Clinical Trials Overview

WRAPSODY Endovascular Stent Graft – Arteriovenous Fistula – Prospective, Multicenter, Observational Study to Evaluate the Merit WRAPSODY Endoprosthesis for Treatment of Stenosis or Occlusion within the Dialysis Outflow Circuit of an Arteriovenous (AVF) Fistula or AV Graft (AVG) (The WRAP Registry)

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Aegis II Abdominal Aortic Stent Graft System – Product Status

Aegis II Abdominal Aortic Stent Graft System – Product Description

PerMed Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

PerMed Branch Stent Graft – Product Status

PerMed Branch Stent Graft – Product Description

PerMed Biomedical Engineering Co Ltd – Ongoing Clinical Trials Overview

PerMed Branch Stent Graft – A Prospective, Multicenter, Open, Randomized Controlled, Non Inferiority Clinical Trial to Evaluate the Safety and Efficacy the Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection

Red Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

Non Modular Branched Endoprosthesis – Product Status

Non Modular Branched Endoprosthesis – Product Description

Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Cratos Branched Aortic Stent Graft System – Product Status

Cratos Branched Aortic Stent Graft System – Product Description

Multi-Branch Aortic Stent – Product Status

Multi-Branch Aortic Stent – Product Description

Shanghai MicroPort Endovascular MedTech Group Co Ltd – Ongoing Clinical Trials Overview

Cratos Branched Aortic Stent Graft System – A Prospective, Multicenter, Single-group Clinical Trial to Evaluate the Efficacy and Safety of the Cratos Branch Aortic Covered Stent System in the Treatment of Stanford Type B Aortic Dissection

Cratos Branched Aortic Stent Graft System – Evaluation of Cratos Branch Stent Graft System in Treatment of Descending Aorta Lesions

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

Aortic Stent Graft – Product Status

Aortic Stent Graft – Product Description

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

Amplatzer AAA Vascular Graft – Product Status

Amplatzer AAA Vascular Graft – Product Description

Amplatzer Peripheral Vascular Graft – Product Status

Amplatzer Peripheral Vascular Graft – Product Description

Amplatzer TAA Vascular Graft – Product Status

Amplatzer TAA Vascular Graft – Product Description

Stanford University Pipeline Products & Ongoing Clinical Trials Overview

Dacron Graft – Product Status

Dacron Graft – Product Description

Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview

BoulEVARd Stent – Product Status

BoulEVARd Stent – Product Description

RelayBranch Thoracic Stent-Graft System – Product Status

RelayBranch Thoracic Stent-Graft System – Product Description

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Status

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Description

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Status

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Description

Thoracoabdominal Hybrid Device – Product Status

Thoracoabdominal Hybrid Device – Product Description

Terumo Aortic – Ongoing Clinical Trials Overview

RelayBranch Thoracic Stent-Graft System – A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery

RelayBranch Thoracic Stent-Graft System – Cerebral Hemodynamics and Microemboli During Placement of RelayBranch Thoracic Stent-Graft System

RelayBranch Thoracic Stent-Graft System – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain”

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Thoraflex Hybrid and Relay Extension Post-Approval Study

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

Hybrid Stent Graft – Product Status

Hybrid Stent Graft – Product Description

The Lundquist Institute Pipeline Products & Ongoing Clinical Trials Overview

Multi-Branched Stent Graft – Product Status

Multi-Branched Stent Graft – Product Description

Thoracic-Abdominal Endoluminal Graft – Product Status

Thoracic-Abdominal Endoluminal Graft – Product Description

TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview

Ovation Thoracic Stent Graft System – Product Status

Ovation Thoracic Stent Graft System – Product Description

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

Expansible Ascending Aortic Graft – Product Status

Expansible Ascending Aortic Graft – Product Description

University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview

Shape Memory Polymer Arterial Stent – Product Status

Shape Memory Polymer Arterial Stent – Product Description

University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

Endograft – Product Status

Endograft – Product Description

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

Cardiovascular Graft – Product Status

Cardiovascular Graft – Product Description

University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Aortic Stent Graft – Product Status

Aortic Stent Graft – Product Description

Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

Tumbao EndoVascular Aortic Repair System – Product Status

Tumbao EndoVascular Aortic Repair System – Product Description

W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview

GORE Ascending Stent Graft – Product Status

GORE Ascending Stent Graft – Product Description

W. L. Gore & Associates Inc – Ongoing Clinical Trials Overview

GORE Ascending Stent Graft – Evaluation of the GORE Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Thoracic Aorta Stent Graft System – Product Status

Thoracic Aorta Stent Graft System – Product Description

Glossary

Figures

Aortic Stent Grafts – Pipeline Products by Stage of Development

Aortic Stent Grafts – Pipeline Products by Segment

Aortic Stent Grafts – Pipeline Products by Territory

Aortic Stent Grafts – Pipeline Products by Regulatory Path

Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

Aortic Stent Grafts – Ongoing Clinical Trials

Frequently asked questions

Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.